Rebecca Bechhold to Cyclophosphamide
This is a "connection" page, showing publications Rebecca Bechhold has written about Cyclophosphamide.
Connection Strength
0.031
-
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score. Breast Cancer Res Treat. 2015 Nov; 154(2):299-308.
Score: 0.031